The result indicated FGF19 expression was much higher in CRC than nontumor tissues (Figure 5G), and FGF19 had a positive association with worse tumor differentiation, more frequent lymph node metastasis, an increased incidence of distant metastasis and higher AJCC staging (Table S5). This evidence concerns the gene FGF19 and neoplasm.